Logo Logo
Hilfe
Kontakt
Switch language to English
Preclinical investigation of immunomodulatory thermosensitive liposomes
Preclinical investigation of immunomodulatory thermosensitive liposomes
Within this thesis, two relevant immunoadjuvants were encapsulated in DPPG2-TSL and the impact on pharmacokinetic, biodistribution and therapeutic efficacy evaluated in vivo, in comparison to un-encapsulated, free compound. For the first time, the STING agonist ADU-S100 (ADU) was loaded in DPPG2-TSL under two different osmotic conditions: hypo- and isosmotic and subsequently tested in vivo. In addition, the TLR 7/8 Agonist Resiquimod (R848) was formulated in DPPG2-TSL-R848 and subsequently tested in vivo. Overall, the encapsulation enhanced in vivo delivery of encapsulated compound and has shown great potential for future research.
Liposomes, Nanopartikel, Immunoncology, targeted delivery, preclinical
Heiß, Bettina Sonja
2023
Englisch
Universitätsbibliothek der Ludwig-Maximilians-Universität München
Heiß, Bettina Sonja (2023): Preclinical investigation of immunomodulatory thermosensitive liposomes. Dissertation, LMU München: Tierärztliche Fakultät
[thumbnail of Heiss_Bettina_Sonja.pdf]
Vorschau
PDF
Heiss_Bettina_Sonja.pdf

7MB

Abstract

Within this thesis, two relevant immunoadjuvants were encapsulated in DPPG2-TSL and the impact on pharmacokinetic, biodistribution and therapeutic efficacy evaluated in vivo, in comparison to un-encapsulated, free compound. For the first time, the STING agonist ADU-S100 (ADU) was loaded in DPPG2-TSL under two different osmotic conditions: hypo- and isosmotic and subsequently tested in vivo. In addition, the TLR 7/8 Agonist Resiquimod (R848) was formulated in DPPG2-TSL-R848 and subsequently tested in vivo. Overall, the encapsulation enhanced in vivo delivery of encapsulated compound and has shown great potential for future research.